Transcatheter Aortic Valve Replacement leaders Anuj Gupta, MD, and Bartley Griffith, MD

Transcatheter aortic valve replacement (TAVR) uses thin tubes (catheters) and collapsible valves to avoid open-heart surgery and the need for a heart-lung machine.

This new, less invasive procedure provides effective treatment options to patients with severe aortic stenosis or aortic prosthetic valve failure who are at a wide range of risk for surgical aortic valve replacement.

We will also be participating in a randomized controlled clinical trial investigating whether TAVR is equivalent to surgical aortic valve replacement (SAVR) in patients who are at standard risk or low risk for SAVR.

Further advances are in the works, though, and we expect eventual approval to treat a wider range of patients with this promising approach.

Our physicians will explain the procedure in detail during your office appointment. You can also learn more by downloading our Heart Valve Patient Guide.